Antisense oligodeoxynucleotides against the muscarinic m2, but not m4, receptor supports its role as autoreceptors in the rat hippocampus

Molecular Brain Research

Volumn 67, Issue 1, 1999, Pages 98-106

  Kitaichi, Kiyoyuki ^a   Hori, Takafumi ^a   Srivastava, Lalit K ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Acetylcholine; Alzheimer's disease; Antisense; Hippocampus; In vivo dialysis; Muscarinic m2 receptor

Indexed keywords

ACETYLCHOLINE; ANTISENSE OLIGODEOXYNUCLEOTIDE; AUTORECEPTOR; CHOLINE ACETYLTRANSFERASE; MUSCARINIC M2 RECEPTOR; MUSCARINIC M4 RECEPTOR; N [2 [2 (DIPROPYLAMINOMETHYL) 1 PIPERIDYL]ETHYL] 5,11 DIHYDRO 6 OXO 6H PYRIDO[2,3 B][1,4]BENZODIAZEPINE 11 CARBOXAMIDE; RECEPTOR SUBTYPE;

ACETYLCHOLINE RELEASE; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; GAS CHROMATOGRAPHY; HIPPOCAMPUS; MALE; MASS SPECTROMETRY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RAT;

ACETYLCHOLINE; ANIMALS; ANTISENSE ELEMENTS (GENETICS); AUTORECEPTORS; BRAIN CHEMISTRY; CHOLINE O-ACETYLTRANSFERASE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HIPPOCAMPUS; MALE; MICRODIALYSIS; MUSCARINIC ANTAGONISTS; PARASYMPATHOLYTICS; PIRENZEPINE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, MUSCARINIC M2; RECEPTOR, MUSCARINIC M4; RECEPTORS, MUSCARINIC; TRITIUM;

ANIMALIA; HIPPOCAMPUS HIPPOCAMPUS;

EID: 0033528696     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(99)00047-9     Document Type: Article

References (61)

1. P. Ambuhl, R. Gyurko, M.I. Phillips, A decrease in angiotensin receptor binding in rat brain nuclei by antisense oligonucleotides to the angiotensin ATI receptor, Regul. Pept. 59 (1995) 171-182.
2. 1-like agonists in rats, J. Neurosci. 16 (1996) 4823-4834.
3. D.M. Araujo, P.A. Lapchak, Y. Robitaille, S. Gauthier, R. Quirion, Differential alteration of cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease, J. Neurochem. 50 (1988) 1914-1923.
4. I. Aubert, D.M. Araujo, D. Cécyre, Y. Robitaille, S. Gauthier, R. Quirion, Comparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases, J. Neurochem. 58 (1992) 529-541.
5. I. Aubert, W. Rowe, M.J. Meaney, S. Gauthier, R. Quirion, Cholinergic markers in aged cognitively impaired Long-Evans rats, Neuroscience 67 (1995) 277-292.
6. 2 through a correlation of in vivo microdialysis and in vitro receptor binding data, J. Pharmacol. Exp. Ther. 273 (1995) 273-279.
7. T.J. Bonner, N.J. Buckly, A.C. Young, M.R. Brann, Identification of a family of muscarinic acetylcholine receptor genes, Science 237 (1987) 527-532.
8. T.I. Bonner, A.C. Young, M.R. Brann, N.J. Buckley, Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes, Neuron 1 (1988) 403-410.
9. D.M. Bowen, C.B. Smith, P. White, A.N. Davison, Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies, Brain 99 (1976) 459-496.
10. M.M. Bradford, A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding, Anal. Biochem. 72 (1976) 248-254.
11. D.A. Brown, S.H. Kang, S.M. Gryaznov, L. DeDionisio, O. Heidenreich, S. Sullivan, X. Xu, M.I. Nerenberg, Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding, J. Biol. Chem. 269 (1994) 26801-26805.
12. N.J. Buckley, T.I. Bonner, M.R. Brann, Localization of a family of muscarinic receptor mRNAs in rat brain, J. Neurosci. 8 (1988) 4646-4652.
13. M.P. Caulfield, Muscarinic receptors - characterization, coupling and function, Pharmacol. Ther. 58 (1993) 319-379.
14. P. Davies, A.J.R. Maloney, Selective loss of central cholinergic neurons in Alzheimer's disease, Lancet 2 (1976) 1403.
15. 2 antagonists: novel structures and pharmacology, Life Sci. 52 (1993) 497-503.
16. F. Dörje, J. Wess, G. Lambrecht, R. Tacke, E. Mutschler, M.R. Brann, Antagonist binding profiles of five cloned human muscarinic receptor subtypes, J. Pharmacol. Exp. Ther. 256 (1991) 727-733.
17. 3H]AF-DX 384, Biochem. Pharmacol. 40 (1990) 1674-1676.
18. F. Fonnum, Radiochemical microassays for the determination of choline acetyltransferase and acetylcholinetransferase activities, J. Biochem. 115 (1969) 465-472.
19. J. Gocayne, D.A. Robinson, M.G. Fitzgerald, F.-Z. Chung, A.R. Kerlavage, K.-U. Lentes, J. Lai, C.-D. Wang, C.M. Fraser, J.C. Venter, Primary structure of rat cardiac beta-adrenergic and muscarinic cholinergic receptors obtained by automated DNA sequence analysis: further evidence for a multigene family, Proc. Natl. Acad. Sci. USA 84 (1987) 8296-8300.
20. 4-selective muscarinic antagonist, Life Sci. 13-14 (1997) 1168.
21. 1 receptors: a combined receptor autoradiography and in vivo dialysis study, J. Neurosci. 15 (1995) 7150-7157.
22. 5 receptors in the modulation of hippocampal acetylcholine release revealed by antisense oligonucleotides, Soc. Neurosci. Abstr. 22 (1996) 1030.
23. E.C. Hulme, N.J.M. Birdsall, N.J. Buckley, Muscarinic receptor subtypes, Annu. Rev. Pharmacol. Toxicol. 30 (1990) 633-673.
24. D.J. Jenden, I. Hanin, Gas chromatographic microestimation of choline and acetylcholine after N-demethylation by sodium benzenethiolate, in: I. Hanin (Ed.), Choline and Acetylcholine: Handbook of Chemical Assay Methods, Raven Press, New York, 1974, pp. 135-150.
25. 3H]AF-DX 116 and effect of AF-DX 116 on endogenous acetylcholine release from rat brain slices, Brain Res. 496 (1989) 285-294.
26. A.I. Levey, C.I. Kitt, W.F. Simonds, D.L. Price, M.R. Brann, Identification and localization of muscarinic acetylcholine receptor protein in brain with subtype-specific antibodies, J. Neurosci. 11 (1991) 3218-3226.
27. 4 muscarinic acetylcholine receptor proteins in rat hippocampus and regulation by cholinergic innervation, Neuroscience 15 (1995) 4077-4092.
28. M. Marchi M, M. Raiteri, Interaction acetylcholine-glutamate in rat hippocampus: involvement of two subtypes of M-2 muscarinic receptors, J. Pharmacol. Exp. Ther. 248 (1989) 1255-1260.
29. M.R. Marien, J.W. Richard, Drug effects on the release of endogenous acetylcholine in vivo: measurement by intracerebral dialysis and gas chromatography-mass spectrometry, J. Neurochem. 54 (1990) 2016-2023.
30. 2 muscarinic receptors in the cerebral cortex in Alzheimer's diseases and experimental cholinergic denervation, Science 228 (1985) 1115-1117.
31. M.D. Matteucci, R.W. Wagner, In pursuit of antisense, Nature 384 (1996) 20-22.
32. M. McKinney, J.T. Coyle, The potential for muscarinic receptor subtype-specific pharmacology for Alzheimer's disease, Mayo Clin. Proc. 66 (1991) 1225-1237.
33. M. McKinney, J.H. Miller, P.J. Aagaard, Pharmacological characterization of the rat hippocampal muscarinic autoreceptor, J. Pharmacol. Exp. Ther. 264 (1993) 74-78.
34. 2 muscarinic receptor proteins with asymmetric synapses in the primate cerebral cortex: morphological evidence for cholinergic modulation of excitatory neurotransmission, Proc. Natl. Acad. Sci. USA 90 (1993) 5194-5198.
35. 3 receptor antisense influences dopamine synthesis in rat brain, NeuroReport 6 (1995) 573-576.
36. G. Paxinos, D. Watson, The Rat Brain in Stereotaxic Coordinates, Academic Press, New York, 1987.
37. E.K. Perry, R.H. Perry, G. Blessed, B.E. Tomlinson, Necropsy evidence of central cholinergic deficits in senile dementia, Lancet 1 (1977) 189.
38. 2 receptor antagonist, improves cognitive performance following traumatic brain injury in rats, Brain Res. 686 (1995) 37-43.
39. 3H]acetylcholine release from rat hippocampal slices, J. Pharmacol. Exp. Ther. 244 (1988) 213-217.
40. R. Quirion, J. Richard, A. Wilson, Muscarinic and nicotinic modulation of cortical acetylcholine release monitored by in vivo microdialysis in freely moving adult rats, Synapse 17 (1994) 92-100.
41. 2-muscarinic receptor antagonist in aged memory-impaired rats, J. Neurosci. 15 (1995) 1455-1462.
42. M. Raiteri, R. Leardi, M. Marchi, Heterogeneity of presynaptic muscarinic receptors regulating neurotransmitter release from rat brain, J. Pharmacol. Exp. Ther. 238 (1984) 209-214.
43. 3 receptors, Br. J. Pharmacol. 99 (1990) 753-761.
44. 4 muscarinic acetylcholine receptor immunoreactivity in septohippocampal neurons and other identified hippocampal afferents, J. Comp. Neurol. 375 (1996) 406-416.
45. 2: diverse functional implications of differential synaptic localization, Life Sci. 60 (1997) 1031-1038.
46. 2 autoreceptors in the motor action of cocaine, J. Pharmacol. Exp. Ther. 46 (1994) 51-57.
47. 1 muscarinic receptor modulates spontaneous release of acetylcholine from rat basal forebrain slices, Neurosci. Lett. 118 (1988) 209-212.
48. A. Szklarczyk, L. Kaczmarek, Antisense oligodeoxynucleotides: stability and distribution after intracerebral injection into rat brain, J. Neurosci. Methods 60 (1995) 181-187.
49. S. Tucek, Choline acetyltransferase, in Acetylcholine Synthesis in Neurons, Chapman & Hall, London, 1978, pp. 23-32.
50. M.G. Vannucchi, C. Scali, S.R. Kopf, G. Pepeu, F. Casamenti, Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats, Neuroscience 79 (1997) 837-846.
51. 2 receptor mRNA expression and receptor binding in cholinergic and non-cholinergic cells in the rat brain: a correlative study using in situ hybridization histochemistry and receptor autoradiography, Neuroscience 47 (1992) 367-393.
52. 4 receptors in the rat brain: evidence from combined in situ hybridization and receptor autoradiography, Synapse 11 (1992) 171-183.
53. M.T. Vilaró, J.M. Palacios, G. Mengod, Multiplicity of muscarinic autoreceptor subtypes? Comparison of the distribution of cholinergic cells and cells containing mRNA for five subtypes of muscarinic receptors in the rat brain, Mol. Brain Res. 21 (1994) 30-46.
54. R.W. Wagner, The state of the art in antisense research, Nature Med. 1 (1995) 1116-1118.
55. C. Wahlestedt, E. Golanov, S. Yamamoto, F. Yee, H. Ericson, H. Yoo, C.E. Inturrisi, D.J. Reis, Antisense oligodeoxynucleotides to NMDA-R1 receptor channel protect cortical neurons from excitotoxicity and reduce focal ischaemic infarctions, Nature 363 (1993) 260-263.
56. C. Wahlestedt, E.M. Pich, G.F. Koob, F. Yee, M. Heilig, Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides, Science 259 (1993) 528-531.
57. S.J. Wall, B.B. Wolfe, L.F. Kromer, Cholinergic deafferentation of dorsal hippocampus by fimbria-fornix lesioning differentially regulates subtypes (ml-m5) of muscarinic receptors, J. Neurochem. 62 (1994) 1345-1351.
58. 2 messenger RNA, Neuroscience 55 (1993) 607-612.
59. P.L. Wood, A. Peloquin, Increases in choline levels in rat brain elicited by meclofenate, Neuropsychopharmacology 18 (1982) 519-523.
60. Y. Yaida, T.S. Nowak Jr., Distribution of phosphodiester and phosphorothioate oligonucleotides in rat brain after intraventricular and intrahippocampal administration determined by in situ hybridization, Regul. Pept. 59 (1995) 193-199.
61. Z. Zang, W. Florjin, I. Creese, Reduction in muscarinic receptors by antisense oligodeoxynucleotide, Biochem. Pharmacol. 48 (1994) 225-228.